Monoclonal Antibodies

Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis

This study evaluates new RSV intervention strategies using mathematical modelling and economic analysis, highlighting the cost-effectiveness of seasonal programmes.

Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales

This study evaluates the cost-effectiveness of Nirsevimab intervention programmes for RSV prevention in England and Wales.